Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tretinoin × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 47 Myeloid 13 Plasma cell 9 Dermatologic 7 Thoracic 5 Lymphoid 5 CNS 5 Gastrointestinal 4 Classical hematology 4 Breast 4 Tumor-Agnostic 3 Genitourinary 3 Sarcoma 1 Other solid neoplasm 1 NET 1 Head & Neck 1 Gynecologic 1 Endocrine 1

Conditions

Oligometastatic Disease 1

Interventions

Cisplatin 136 Carboplatin 115 pembrolizumab 113 Paclitaxel 94 Injections 90 Pemetrexed 88 Gemcitabine 80 Irinotecan 70 Cyclophosphamide 66 Docetaxel 61 Nivolumab 60 Bevacizumab 57 Fluorouracil 47 Oxaliplatin 45 Capecitabine 43 atezolizumab 41 Leucovorin 40 tislelizumab 37 Etoposide 36 toripalimab 30 fludarabine 28 Ipilimumab 28 Topotecan 26 Drug Therapy 26 Radiotherapy 25 durvalumab 24 Early Intervention, Educational 24 Vincristine 23 Doxorubicin 23 Specimen Handling 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06439888 2025-12-01

LySATRA

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Other solid neoplasm

Oligometastatic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡